GALT Galectin Therapeutics Inc. - Common Stock
GALT Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
GALT Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
GALT Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
- Starker Kauf 2 28,6%
- Kauf 4 57,1%
- Halten 1 14,3%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
1 Analysten · 2026-08-16Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.08 | $-0.06 | -0.02% |
| 31. Dezember 2025 | $-0.08 | $-0.10 | 0.02% |
| 30. September 2025 | $-0.13 | $-0.11 | -0.02% |
| 30. Juni 2025 | $-0.12 | $-0.16 | 0.04% |
| 31. März 2025 | $-0.15 | $-0.20 | 0.05% |
| 31. Dezember 2024 | $-0.19 | $-0.16 | -0.03% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| GALT | $271M | -8.7 | — | — | 25.0% | — |
| RCKT | — | — | — | — | — | — |
| ENTA | $256M | -3.1 | -3.4% | -125.4% | -103.5% | — |
| DMAC | $428M | — | — | — | -78.7% | — |
| STRO | $99M | -0.5 | 65.2% | -186.5% | 232.2% | — |
| ZNTL | $93M | -0.7 | — | — | -49.5% | — |
| IPSC | $87M | -7.1 | 1556.8% | -8.8% | -5.2% | — |
| SABS | — | — | — | — | — | — |
| ABEO | $290M | 5.2 | 147.5% | 1223.1% | 44.1% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $14M | $37M | $32M | $32M | $24M | $18M | $7M | $6M | $12M | $15M | $13M | $8M | |
| SG&A Expense | $6M | $6M | $6M | $7M | $6M | $5M | $6M | $7M | $5M | $6M | $7M | $7M | |
| Operating Expenses | $20M | $42M | $38M | $38M | $30M | $23M | $13M | $14M | $16M | $21M | $20M | $15M | |
| Operating Income | $-20M | $-42M | $-38M | $-38M | $-30M | $-23M | $-13M | $-14M | $-16M | $-21M | $-20M | $-15M | |
| Interest Expense | · | · | $3M | $1M | $489.0K | $87.0K | $87.0K | $336.0K | $12.0K | · | · | · | |
| Interest Income | $126.0K | $338.0K | $230.0K | $52.0K | $3.0K | $66.0K | $231.0K | $38.0K | $24.0K | $45.0K | $52.0K | $42.0K | |
| Other Non-op | $-11M | $-5M | $-3M | $-424.0K | $-348.0K | $-21.0K | $144.0K | $-298.0K | $12.0K | $45.0K | $52.0K | $-358.0K | |
| Income Tax | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-31M | $-47M | $-41M | $-39M | $-31M | $-23M | $-13M | $-14M | $-16M | $-21M | $-20M | $-16M | |
| EPS (Basic) | $-0.48 | $-0.76 | $-0.74 | $-0.65 | $-0.52 | $-0.41 | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.48 | $-0.76 | $-0.74 | $-0.65 | $-0.52 | $-0.41 | · | · | · | · | · | · | |
| Shares (Basic) | 63,903,000 | 62,309,000 | 60,159,000 | 59,391,000 | 58,527,000 | 57,029,000 | · | · | · | · | · | · | |
| Shares (Diluted) | 63,903,000 | 62,309,000 | 60,159,000 | 59,391,000 | 58,527,000 | 57,029,000 | · | · | · | · | · | · | |
| EBITDA | $-20M | · | $-38M | $-38M | $-30M | $-23M | $-13M | $-14M | · | · | · | $-15M |
Bilanz 21
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $18M | $15M | $26M | $19M | $40M | $27M | $47M | $8M | $3M | $15M | $26M | $29M | |
| Prepaid Expense | $2M | $2M | $2M | $2M | $2M | $2M | $729.0K | $579.0K | $766.0K | $432.0K | $554.0K | $533.0K | |
| Current Assets | $19M | $17M | $28M | $21M | $42M | $29M | $48M | $9M | $4M | $16M | $26M | $30M | |
| PP&E (Net) | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | $0 | $1.0K | |
| PP&E (Gross) | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | |
| Accum. Depreciation | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $73.0K | |
| Intangibles | · | · | · | · | · | · | · | $0 | $0 | $1.0K | $8.0K | $15.0K | |
| Other Non-current Assets | $96.0K | $243.0K | $490.0K | $733.0K | $7.0K | $135.0K | $258.0K | $174.0K | $342.0K | · | · | · | |
| Total Assets | $20M | $17M | $28M | $21M | $42M | $30M | $48M | $9M | $4M | $16M | $26M | $30M | |
| Accounts Payable | $3M | $6M | $6M | $4M | $2M | $1M | $2M | $297.0K | $608.0K | $910.0K | $448.0K | $906.0K | |
| Accrued Liabilities | $5M | $8M | $9M | $9M | $7M | $4M | $1M | $2M | $2M | $3M | $845.0K | $729.0K | |
| Current Liabilities | $8M | $35M | $16M | $13M | $9M | $5M | $3M | $2M | $3M | $4M | $1M | $2M | |
| Capital Leases | · | · | $20.0K | $66.0K | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $0 | · | $20.0K | $66.0K | $0 | $8.0K | $52.0K | $0 | · | · | · | $0 | |
| Total Liabilities | $146M | $121M | $88M | $53M | $39M | $5M | $3M | $2M | $3M | $4M | $1M | $2M | |
| Common Stock | $65.0K | $62.0K | $61.0K | $59.0K | $59.0K | $56.0K | $56.0K | $41.0K | $36.0K | $33.0K | $28.0K | $22.0K | |
| Paid-in Capital | $304M | $296M | $292M | $275M | $271M | $262M | $260M | $194M | $173M | $167M | $158M | $140M | |
| Retained Earnings | $-433M | $-402M | $-354M | $-310M | $-271M | $-240M | $-216M | $-196M | $-181M | $-164M | $-140M | $-119M | |
| Stockholders' Equity | $-128M | $-105M | $-62M | $-34M | $893.0K | $22M | $44M | $5M | $-530.0K | $10M | $18M | $21M | |
| Liabilities + Equity | $20M | $17M | $28M | $21M | $42M | $30M | $48M | $9M | $4M | $16M | $26M | $30M | |
| Shares Outstanding | 65,201,995 | 63,157,235 | 61,852,914 | 59,426,005 | 59,341,305 | 57,077,055 | 56,894,642 | 41,190,905 | 35,789,388 | 32,912,942 | 28,825,033 | 22,277,283 |
Cashflow 11
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $1.0K | $7.0K | $7.0K | $10.0K | |
| Stock-based Comp | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $4M | $1M | $2M | $3M | $4M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | $0 | $1.0K | $7.0K | $7.0K | $8.0K | |
| Other Non-cash | · | · | · | · | · | · | · | $-724.0K | · | · | · | $-718.0K | |
| Operating Cash Flow | $-24M | $-42M | $-33M | $-31M | $-24M | $-21M | $-11M | $-10M | $-16M | $-16M | $-17M | $-12M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | · | · | · | |
| Stock Issued | $3M | $0 | · | $0 | $7M | $263.0K | $50M | $15M | $4M | $6M | $14M | $29M | |
| Net Stock Activity | $3M | · | · | $0 | $7M | $263.0K | $50M | $15M | · | · | · | $29M | |
| Financing Cash Flow | $26M | $31M | $40M | $10M | $37M | $263.0K | $50M | $15M | $4M | · | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | $5M | $-12M | $-10M | $-3M | $19M |
Rentabilität 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -166.6% | · | -166.0% | -122.9% | -85.5% | -60.1% | -46.3% | -211.1% | · | · | · | -78.2% | |
| ROE | 25.0% | · | 71.7% | 133.8% | -725.2% | -89.8% | -29.0% | -223.8% | · | · | · | -139.2% |
Liquidität & Solvenz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | · | 1.8 | 1.6 | 4.6 | 5.5 | 17.1 | 4.2 | · | · | · | 17.4 | |
| Quick Ratio | 2.2 | · | 1.6 | 1.4 | 4.4 | 5.0 | 16.8 | 3.9 | · | · | · | 17.1 | |
| Interest Coverage | · | · | -13.6 | -37.1 | -61.7 | -269.5 | -154.5 | -40.5 | · | · | · | · |
Bewertung (TTM) 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-31M | · | $-41M | $-39M | $-31M | $-23M | $-13M | $-14M | $-16M | $-21M | $-20M | $-16M | |
| Market Cap | $271M | · | $103M | $67M | $123M | $128M | $163M | $141M | · | · | · | $77M | |
| P/E | -8.7 | · | -2.2 | -1.7 | -4.0 | -5.5 | · | · | · | · | · | · | |
| P/B | -2.1 | · | -1.7 | -2.0 | 137.6 | 5.7 | 3.7 | 27.3 | · | · | · | 3.6 | |
| P / Tangible Book | · | · | · | · | 137.6 | 5.7 | · | · | · | · | · | · | |
| P / Cash Flow | -11.4 | · | -3.1 | -2.2 | -5.1 | -6.2 | -15.0 | -13.9 | · | · | · | -6.2 | |
| Earnings Yield | -11.5% | · | -44.6% | -57.5% | -25.1% | -18.3% | · | · | · | · | · | · |
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $2M | $2M | $3M | $3M | $6M | $11M | $8M | $10M | $8M | $8M | $8M | $7M | $9M | $9M | $7M | |
| SG&A Expense | $2M | $2M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $4M | $4M | $3M | $4M | $5M | $8M | $12M | $9M | $11M | $10M | $10M | $9M | $9M | $10M | $11M | $8M | |
| Operating Income | $-4M | $-4M | $-3M | $-4M | $-5M | $-8M | $-12M | $-9M | $-11M | $-10M | $-10M | $-9M | $-9M | $-10M | $-11M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | $847.0K | $835.0K | $650.0K | $460.0K | $308.0K | $269.0K | |
| Interest Income | $28.0K | $36.0K | $26.0K | $39.0K | $26.0K | $35.0K | $85.0K | $93.0K | $80.0K | $80.0K | $74.0K | $62.0K | $50.0K | $44.0K | $30.0K | $18.0K | |
| Other Non-op | $-5M | $-969.0K | $-2M | $-4M | $-3M | $-2M | $461.0K | $-2M | $-1M | $-2M | $-436.0K | $-1M | $-111.0K | $-1M | $-1.0K | $-475.0K | |
| Net Income | $-9M | $-5M | $-6M | $-8M | $-8M | $-10M | $-12M | $-11M | $-12M | $-11M | $-10M | $-10M | $-9M | $-12M | $-11M | $-9M | |
| EPS (Basic) | $-0.14 | $-0.08 | $-0.08 | $-0.13 | $-0.12 | $-0.15 | $-0.19 | $-0.18 | $-0.20 | $-0.19 | $-0.16 | $-0.24 | $-0.15 | $-0.19 | $-0.18 | $-0.14 | |
| EPS (Diluted) | $-0.14 | $-0.08 | $-0.08 | $-0.13 | $-0.12 | $-0.15 | $-0.19 | $-0.18 | $-0.20 | $-0.19 | $-0.16 | $-0.24 | $-0.15 | $-0.19 | $-0.18 | $-0.14 | |
| Shares (Basic) | 65,875,000 | 65,782,000 | -126,953,000 | 64,205,000 | 63,447,000 | 63,204,000 | -124,178,000 | 62,278,000 | 62,233,000 | 61,976,000 | -118,607,000 | 59,704,000 | 59,582,000 | 59,480,000 | -118,748,000 | 59,396,000 | |
| Shares (Diluted) | 65,875,000 | 65,782,000 | -126,953,000 | 64,205,000 | 63,447,000 | 63,204,000 | -124,178,000 | 62,278,000 | 62,233,000 | 61,976,000 | -118,607,000 | 59,704,000 | 59,582,000 | 59,480,000 | -118,748,000 | 59,396,000 | |
| EBITDA | $-4M | $-4M | · | $-4M | $-5M | $-8M | · | $-9M | $-11M | $-10M | · | $-9M | $-9M | $-10M | · | $-8M |
Bilanz 20
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $14M | $18M | $12M | $14M | $7M | $15M | $27M | $26M | $24M | $26M | $20M | $18M | $18M | $19M | $16M | |
| Prepaid Expense | $1M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | |
| Current Assets | $15M | $16M | $19M | $13M | $15M | $9M | $17M | $29M | $27M | $25M | $28M | $22M | $19M | $20M | $21M | $17M | |
| PP&E (Net) | · | · | $0 | · | · | · | $0 | · | · | · | $0 | · | · | · | $0 | · | |
| PP&E (Gross) | · | · | $74.0K | · | · | · | $74.0K | · | · | · | $74.0K | · | · | · | $74.0K | · | |
| Accum. Depreciation | · | · | $74.0K | · | · | · | $74.0K | · | · | · | $74.0K | · | · | · | $74.0K | · | |
| Other Non-current Assets | $167.0K | $68.0K | $96.0K | $136.0K | $175.0K | $243.0K | $243.0K | $306.0K | $368.0K | $430.0K | $490.0K | $552.0K | $613.0K | $673.0K | $733.0K | $793.0K | |
| Total Assets | $15M | $16M | $20M | $13M | $16M | $10M | $17M | $29M | $28M | $26M | $28M | $22M | $20M | $20M | $21M | $18M | |
| Accounts Payable | $4M | $3M | $3M | $5M | $6M | $7M | $6M | $3M | $4M | $4M | $6M | $3M | $2M | $3M | $4M | $2M | |
| Accrued Liabilities | $4M | $4M | $5M | $5M | $5M | $7M | $8M | $12M | $11M | $9M | $9M | $8M | $8M | $9M | $9M | $7M | |
| Current Liabilities | $152M | $7M | $8M | $136M | $11M | $111M | $35M | $25M | $15M | $13M | $16M | $11M | $10M | $12M | $13M | $10M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | $7.0K | $20.0K | $32.0K | $43.0K | $55.0K | $66.0K | $77.0K | |
| Other Non-current Liabilities | $59.0K | · | · | · | · | · | · | $0 | $0 | $7.0K | $20.0K | $32.0K | $44.0K | $55.0K | $66.0K | $77.0K | |
| Total Liabilities | $152M | $146M | $146M | $136M | $133M | $122M | $121M | $121M | $110M | $97M | $88M | $73M | $71M | $63M | $53M | $40M | |
| Common Stock | $66.0K | $65.0K | $65.0K | $64.0K | $63.0K | $63.0K | $62.0K | $62.0K | $62.0K | $61.0K | $61.0K | $61.0K | $59.0K | $59.0K | $59.0K | $59.0K | |
| Paid-in Capital | $308M | $305M | $304M | $301M | $299M | $297M | $296M | $295M | $294M | $292M | $292M | $291M | $277M | $276M | $275M | $274M | |
| Retained Earnings | $-447M | $-438M | $-433M | $-427M | $-419M | $-411M | $-402M | $-390M | $-378M | $-366M | $-354M | $-344M | $-330M | $-321M | $-310M | $-299M | |
| Stockholders' Equity | $-139M | $-132M | $-128M | $-125M | $-119M | $-114M | $-105M | $-94M | $-84M | $-73M | $-62M | $-53M | $-53M | $-44M | $-34M | $-24M | |
| Liabilities + Equity | $15M | $16M | $20M | $13M | $16M | $10M | $17M | $29M | $28M | $26M | $28M | $22M | $20M | $20M | $21M | $18M | |
| Shares Outstanding | 66,311,910 | 65,856,898 | 65,201,995 | 64,472,792 | 64,060,262 | 63,291,585 | 63,157,235 | 62,308,075 | 62,278,125 | 62,148,134 | 61,852,914 | 61,848,657 | 59,582,253 | 59,582,253 | 59,426,005 | 59,426,005 |
Cashflow 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $963.0K | $686.0K | $195.0K | $496.0K | $500.0K | $468.0K | $590.0K | $515.0K | $738.0K | $604.0K | $497.0K | $586.0K | $516.0K | $662.0K | $681.0K | $681.0K | |
| Operating Cash Flow | $-2M | $-4M | $-6M | $-4M | $-7M | $-8M | $-13M | $-9M | $-8M | $-12M | $-5M | $-8M | $-10M | $-11M | $-7M | $-8M | |
| Stock Issued | · | · | $1M | $853.0K | · | · | $0 | $0 | · | · | · | · | · | · | · | $0 | |
| Financing Cash Flow | $2M | $257.0K | $12M | $1M | $13M | $0 | $851.0K | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $0 |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -59.9% | -39.9% | · | -39.1% | -34.8% | -54.4% | · | -43.9% | -51.8% | -49.8% | · | -52.0% | -39.6% | -42.8% | · | -30.7% | |
| ROE | 7.1% | 4.1% | · | 7.5% | 7.4% | 10.3% | · | 15.3% | 18.1% | 19.6% | · | 27.2% | 26.1% | 44.1% | · | 104.0% |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.1 | 2.1 | · | 0.1 | 1.4 | 0.1 | · | 1.1 | 1.9 | 2.0 | · | 2.1 | 2.0 | 1.7 | · | 1.8 | |
| Quick Ratio | 0.1 | 1.9 | · | 0.1 | 1.3 | 0.1 | · | 1.1 | 1.8 | 1.9 | · | 1.9 | 1.8 | 1.5 | · | 1.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -9.2 | · | -11.0 | -13.9 | -22.5 | · | -30.2 |
Bewertung (TTM) 6
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-30M | $-30M | · | $-37M | $-41M | $-45M | · | $-46M | $-43M | $-43M | · | $-40M | $-39M | $-40M | · | $-37M | |
| Market Cap | $308M | $184M | · | $273M | $135M | $77M | · | $171M | $141M | $149M | · | $119M | $86M | $125M | · | $97M | |
| P/E | -9.9 | -5.8 | · | -7.3 | -3.2 | -1.7 | · | -3.4 | -2.9 | -3.1 | · | -2.7 | -2.2 | -3.2 | · | -2.7 | |
| P/B | -2.2 | -1.4 | · | -2.2 | -1.1 | -0.7 | · | -1.8 | -1.7 | -2.0 | · | -2.3 | -1.6 | -2.8 | · | -4.0 | |
| P / Cash Flow | · | -47.5 | · | · | · | -10.0 | · | · | · | -12.3 | · | · | · | -11.6 | · | · | |
| Earnings Yield | -10.1% | -17.2% | · | -13.7% | -30.8% | -59.0% | · | -29.4% | -34.5% | -32.2% | · | -37.5% | -44.4% | -31.4% | · | -37.4% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-31M | $-47M | $-41M | $-39M | $-31M |
| Verwässerte EPS | $-0.48 | $-0.76 | $-0.74 | $-0.65 | $-0.52 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 2.4 | — | 1.8 | 1.6 | 4.6 |
| Quick Ratio | 2.2 | — | 1.6 | 1.4 | 4.4 |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 110 Einreicher · $56.5M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 23 (+3 vs. Vorquartal) | 17 (+4 vs. Vorquartal) | 26 (0 vs. Vorquartal) | 27 (+3 vs. Vorquartal) | +3.1M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $10.059.822 | 2.168.065 | 17,79% | Aktien |
| OSAIC HOLDINGS, INC. | $5.538.880 | 1.193.725 | 9,80% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $5.207.646 | 1.122.001 | 9,21% | Aktien |
| GREAT POINT PARTNERS LLC | $3.712.000 | 800.000 | 6,56% | Kaufoption |
| Wealthspire Advisors, LLC | $3.349.097 | 721.788 | 5,92% | Aktien |
| STATE STREET CORP | $2.634.495 | 567.779 | 4,66% | Aktien |
| COMMONWEALTH EQUITY SERVICES, LLC | $1.889.000 | 407.113 | 3,34% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.700.449 | 366.476 | 3,01% | Aktien |
| MARSHALL WACE, LLP | $1.685.893 | 363.339 | 2,98% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.520.834 | 327.766 | 2,69% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $1.476.657 | 318.245 | 2,61% | Aktien |
| LPL Financial LLC | $1.324.163 | 285.380 | 2,34% | Aktien |
| Geneos Wealth Management Inc. | $1.115.581 | 240.427 | 1,97% | Aktien |
| CITADEL ADVISORS LLC | $981.824 | 211.600 | 1,74% | Verkaufsoption |
| RETIREMENT GUYS FORMULA LLC | $979.286 | 211.053 | 1,73% | Aktien |
| CITADEL ADVISORS LLC | $921.973 | 198.701 | 1,63% | Aktien |
| Sovran Advisors, LLC | $874.610 | 257.997 | 1,55% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $822.194 | 177.197 | 1,45% | Aktien |
| NATIONAL BANK OF CANADA /FI/ | $779.056 | 167.900 | 1,38% | Aktien |
| DEBUSSY CAPITAL MANAGEMENT LP | $721.449 | 258.584 | 1,28% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $700.640 | 151.000 | 1,24% | Kaufoption |
| BLAIR WILLIAM & CO/IL | $692.673 | 149.283 | 1,22% | Aktien |
| CITADEL ADVISORS LLC | $597.168 | 128.700 | 1,06% | Kaufoption |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $540.207 | 116.424 | 0,96% | Aktien |
| HighTower Advisors, LLC | $436.740 | 94.125 | 0,77% | Aktien |
| SIMPLEX TRADING, LLC | $386.284 | 83.251 | 0,68% | Aktien |
| GOLDMAN SACHS GROUP INC | $345.931 | 74.554 | 0,61% | Aktien |
| TRUIST FINANCIAL CORP | $315.520 | 68.000 | 0,56% | Aktien |
| Nuveen, LLC | $295.614 | 63.710 | 0,52% | Aktien |
| RHUMBLINE ADVISERS | $224.257 | 48.332 | 0,40% | Aktien |
| HORIZON KINETICS ASSET MANAGEMENT LLC | $217.932 | 46.968 | 0,39% | Aktien |
| SYNOVUS FINANCIAL CORP | $203.280 | 48.000 | 0,36% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $201.112 | 43.343 | 0,36% | Aktien |
| Sanctuary Advisors, LLC | $193.627 | 41.730 | 0,34% | Aktien |
| Pinnacle Financial Partners, Inc. | $193.256 | 41.650 | 0,34% | Aktien |
| Caption Management, LLC | $185.600 | 40.000 | 0,33% | Kaufoption |
| MILLENNIUM MANAGEMENT LLC | $166.404 | 35.863 | 0,29% | Aktien |
| Bank of New York Mellon Corp | $148.350 | 31.972 | 0,26% | Aktien |
| Pekin Hardy Strauss, Inc. | $139.200 | 30.000 | 0,25% | Aktien |
| MetLife Investment Management, LLC | $133.980 | 28.875 | 0,24% | Aktien |
| BANK OF AMERICA CORP /DE/ | $132.454 | 28.546 | 0,23% | Aktien |
| Solutions 4 Wealth, Ltd | $116.125 | 25.027 | 0,21% | Aktien |
| Gladstone Institutional Advisory LLC | $110.896 | 23.900 | 0,20% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $102.386 | 22.066 | 0,18% | Aktien |
| CAHABA WEALTH MANAGEMENT, INC. | $97.440 | 21.000 | 0,17% | Aktien |
| Summit Trail Advisors, LLC | $92.800 | 20.000 | 0,16% | Aktien |
| CITIGROUP INC | $91.422 | 19.703 | 0,16% | Aktien |
| Invesco Ltd. | $88.661 | 19.108 | 0,16% | Aktien |
| Stratos Wealth Partners, LTD. | $88.568 | 19.088 | 0,16% | Aktien |
| JANE STREET GROUP, LLC | $86.768 | 18.700 | 0,15% | Kaufoption |
| Inspire Advisors, LLC | $86.578 | 19.995 | 0,15% | Aktien |
| Mariner, LLC | $85.840 | 18.500 | 0,15% | Aktien |
| Vanguard Global Advisers, LLC | $83.822 | 18.065 | 0,15% | Aktien |
| Archer Investment Corp | $80.741 | 17.401 | 0,14% | Aktien |
| WOLVERINE TRADING, LLC | $75.960 | 18.000 | 0,13% | Kaufoption |
| VANGUARD GROUP INC | $75.150 | 18.065 | 0,13% | Aktien |
| JANE STREET GROUP, LLC | $72.384 | 15.600 | 0,13% | Verkaufsoption |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $67.201 | 16.552 | 0,12% | Aktien |
| XTX Topco Ltd | $66.918 | 14.422 | 0,12% | Aktien |
| Fortis Capital Advisors, LLC | $65.605 | 14.139 | 0,12% | Aktien |
| Belpointe Asset Management LLC | $65.605 | 14.139 | 0,12% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $65.577 | 14.133 | 0,12% | Aktien |
| GROUP ONE TRADING LLC | $63.814 | 13.753 | 0,11% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $63.104 | 13.600 | 0,11% | Aktien |
| SIG BROKERAGE, LP | $63.085 | 13.596 | 0,11% | Aktien |
| Argyle Capital Partners, LLC | $62.060 | 13.375 | 0,11% | Aktien |
| FMR LLC | $60.714 | 13.085 | 0,11% | Aktien |
| Creative Planning | $48.901 | 10.539 | 0,09% | Aktien |
| STOCK YARDS BANK & TRUST CO | $48.720 | 10.500 | 0,09% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $47.402 | 10.216 | 0,08% | Aktien |
| ATWOOD & PALMER INC | $46.400 | 10.000 | 0,08% | Aktien |
| Integrated Wealth Concepts LLC | $46.400 | 10.000 | 0,08% | Aktien |
| Cetera Investment Advisers | $46.400 | 10.000 | 0,08% | Aktien |
| BARCLAYS PLC | $36.146 | 7.790 | 0,06% | Aktien |
| Nuveen Asset Management, LLC | $35.634 | 27.623 | 0,06% | Aktien |
| NORTHERN TRUST CORP | $34.805 | 7.501 | 0,06% | Aktien |
| BlackRock, Inc. | $33.515 | 7.223 | 0,06% | Aktien |
| Blue Trust, Inc. | $32.480 | 7.000 | 0,06% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $31.248 | 11.200 | 0,06% | Aktien |
| Clearstead Advisors, LLC | $27.840 | 6.000 | 0,05% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $27.061 | 5.423 | 0,05% | Aktien |
| MORGAN STANLEY | $21.961 | 4.733 | 0,04% | Aktien |
| Legal & General Group Plc | $21.632 | 4.662 | 0,04% | Aktien |
| Tower Research Capital LLC (TRC) | $21.367 | 4.605 | 0,04% | Aktien |
| Rockefeller Capital Management L.P. | $20.351 | 4.386 | 0,04% | Aktien |
| Ameritas Investment Partners, Inc. | $20.179 | 4.349 | 0,04% | Aktien |
| CoreCap Advisors, LLC | $18.050 | 3.890 | 0,03% | Aktien |
| Activest Wealth Management | $9.280 | 2.000 | 0,02% | Aktien |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $9.168 | 1.976 | 0,02% | Aktien |
| ROYAL BANK OF CANADA | $8.000 | 1.631 | 0,01% | Aktien |
| WELLS FARGO & COMPANY/MN | $7.456 | 1.607 | 0,01% | Aktien |
| Hilton Head Capital Partners, LLC | $3.712 | 800 | 0,01% | Aktien |
| NISA INVESTMENT ADVISORS, LLC | $3.322 | 716 | 0,01% | Aktien |
| DEUTSCHE BANK AG\ | $3.002 | 647 | 0,01% | Aktien |
| UBS Group AG | $2.311 | 498 | 0,00% | Aktien |
| Sterling Capital Management LLC | $1.935 | 417 | 0,00% | Aktien |
| Fortitude Family Office, LLC | $1.726 | 372 | 0,00% | Aktien |
| Global Retirement Partners, LLC | $1.160 | 250 | 0,00% | Aktien |
| SALEM INVESTMENT COUNSELORS INC | $775 | 167 | 0,00% | Aktien |
| JPMORGAN CHASE & CO | $721 | 145 | 0,00% | Aktien |
Unternehmensinsider 40 Insider · 12 Führungskräfte · 29 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Joel Lewis | President and CEO | 16. Januar 2026 A | 832.592 | 0 | 11 | $-709.920 |
| Peter G Traber | President & CEO | 13. Juni 2018 M | 107.333 | 0 | 0 | $0 |
| David Platt | Chairman & CEO | 8. Oktober 2008 P | 6.000 | 0 | 0 | $0 |
| Jack W Callicutt | Chief Financial Officer | 16. Januar 2026 A | 7.614 | 0 | 21 | $-1.000.379 |
| Thomas Mcgauley | Chief Financial Officer | 19. Juni 2013 A | 10.000 | 0 | 0 | $0 |
| Anthony Don Squeglia | Chief Financial Officer | 1. Februar 2010 A | — | 0 | 0 | $0 |
| Carl Laurence Lueders | Chief Financial Officer | 8. März 2007 A | — | 0 | 0 | $0 |
| David A Christopher | FORMER CFO & TREASURER | 14. Oktober 2003 M | 17.729 | 0 | 0 | $0 |
| Maureen Foley | Chief Operating Officer | 1. Februar 2010 A | 5.000 | 0 | 0 | $0 |
| Khurram Jamil | Chief Medical Officer | 14. Juli 2026 M | 0 | 0 | 17 | $-1.435.942 |
| Pol F Boudes | Chief Medical Officer | 24. Januar 2024 A | — | 0 | 0 | $0 |
| Eliezer Zomer | Ex. VP, Mfg. & Product Dev. | 21. April 2009 A | — | 0 | 0 | $0 |
| Richard E Uihlein | Direktor | 31. Juli 2026 M | 44.713.843 | 0 | 0 | $0 |
| Harold H. Shlevin | Direktor | 29. Juni 2026 M | 6.500 | 0 | 14 | $-1.555.866 |
| Henry Brem | Direktor | 12. März 2026 A | — | 0 | 0 | $0 |
| Kary Eldred | Direktor | 6. Februar 2026 P | 65.682 | 3 | 0 | $6.032 |
| Richard A. Zordani Jr. | Direktor | 16. Januar 2026 A | 42.083 | 0 | 0 | $0 |
| Elissa J. Schwartz | Direktor | 16. Januar 2026 A | 1.000 | 0 | 0 | $0 |
| Kevin D Freeman | Direktor | 16. Januar 2026 A | 55.269 | 3 | 0 | $58.575 |
| Gilbert S Omenn | Direktor | 16. Januar 2026 A | 66.769 | 0 | 0 | $0 |
| Gilbert F Amelio | Direktor | 16. Januar 2026 A | 60.614 | 0 | 0 | $0 |
| Benjamin Carson SR | Direktor | 16. Januar 2026 A | — | 0 | 0 | $0 |
| Marc Rubin | Direktor | 23. Januar 2025 A | 13.581 | 0 | 0 | $0 |
| James C Czirr | Direktor | 26. Januar 2023 A | 3.260.697 | 0 | 0 | $0 |
| Stephen Shulman | Direktor | 16. Januar 2019 A | — | 0 | 0 | $0 |
| Theodore Daniel Zucconi | Direktor | 16. April 2018 M | 1.083 | 0 | 0 | $0 |
| John F Mauldin | Direktor | 15. Dezember 2016 A | 42.669 | 0 | 0 | $0 |
| Arthur Greenberg | Direktor | 15. Dezember 2016 A | 109.445 | 0 | 0 | $0 |
| Steven Prelack | Direktor | 15. Dezember 2016 A | 107.189 | 0 | 0 | $0 |
| Herman Paul Pressler | Direktor | 8. April 2015 D | 36.767 | 0 | 0 | $0 |
| Rod D Martin | Direktor | 8. April 2015 D | 202.089 | 0 | 0 | $0 |
| Jerald K Rome | Direktor | 28. März 2013 A | 22.058 | 0 | 0 | $0 |
| Sydney Colin Neill | Direktor | 28. Juni 2011 A | — | 0 | 0 | $0 |
| Mildred S Christian | Direktor | 25. Februar 2009 A | 27.500 | 0 | 0 | $0 |
| Henry Jemil Esber | Direktor | 8. Februar 2009 A | — | 0 | 0 | $0 |
| James Theophile Gourzis | Direktor | 8. Februar 2009 A | 2.000 | 0 | 0 | $0 |
| Burton C Firtel | Direktor | 8. März 2007 A | 129.000 | 0 | 0 | $0 |
| David H Smith | Direktor | 8. März 2007 A | 63.500 | 0 | 0 | $0 |
| Edgar Ben-Josef | Direktor | 9. März 2006 A | — | 0 | 0 | $0 |
| Dale H Conaway | — | 8. Februar 2009 A | 22.806 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Richard E. Uihlein ×3 Einreichungen | 4. August 2026 | 49,30% | Änderung | Passive Anlage | SEC |
| 10X Fund, L.P., 10X Capital Management, LLC, James C. Czirr ×15 Einreichungen | 1. Dezember 2023 | — | Erste Einreichung | Passive Anlage | SEC |
| Rod D. Martin ×9 Einreichungen | 18. Mai 2010 | — | Erste Einreichung | — | SEC |
| James C. Czirr ×12 Einreichungen | 17. Mai 2010 | — | Erste Einreichung | — | SEC |
| 10X Fund, L.P. 10X Capital Management, LLC | 24. März 2009 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 10 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,04% | 165.385 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 275.017 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 35.584 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,01% | 302.350 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,00% | 1.040.485 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,00% | 154.561 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 595.153 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.521.443 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 12.968 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.197 SH | 8. August 2026 | Täglich |